Hydroxypropyl‐β‐cyclodextrin hybrid nanogels as nano‐drug delivery carriers to enhance the solubility of dexibuprofen: Characterization, in vitro release, and acute oral toxicity studies
- 4 September 2017
- journal article
- research article
- Published by Wiley in Advances in Polymer Technology
- Vol. 37 (6), 2171-2185
- https://doi.org/10.1002/adv.21876
Abstract
No abstract availableKeywords
Funding Information
- Higher Education Commission, Pakistan (112-36529-2BM1-104)
This publication has 55 references indexed in Scilit:
- Solubilization of ibuprofen with β-cyclodextrin derivatives: Energetic and structural studiesJournal of Pharmaceutical and Biomedical Analysis, 2011
- Cyclodextrin-Based Polymeric Materials: Synthesis, Properties, and Pharmaceutical/Biomedical ApplicationsBiomacromolecules, 2009
- The development of microgels/nanogels for drug delivery applicationsProgress in Polymer Science, 2008
- CyclodextrinsToxicologic Pathology, 2008
- Estradiol sustained release from high affinity cyclodextrin hydrogelsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Cyclodextrin-based pharmaceutics: past, present and futureNature Reviews Drug Discovery, 2004
- Dexibuprofen: pharmacology, therapeutic uses and safetyInflammopharmacology, 2003
- Hydrogels in pharmaceutical formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in developmentAdvanced Drug Delivery Reviews, 1999
- Losartan: First of a New Class of Angiotensin Antagonists for the Management of HypertensionThe Journal of Clinical Pharmacology, 1996